Trial Profile
Clinical Trials Insight: 700051713
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2009
Price :
$35
*
At a glance
- Drugs S 524101 (Primary)
- Indications Allergic rhinitis; Hypersensitivity
- Focus Therapeutic Use
- Sponsors Stallergenes SA
- 15 Dec 2009 New trial record.